CERVICAL CANCER IN WOMEN

Authors

  • Nasriddinova Khadichabonu Kokand University Andijan branch Medical work 1 course 24_20 group

Keywords:

cervical cancer, human papillomavirus, HPV vaccine, Pap smear, colposcopy, gynecologic oncology.

Abstract

Cervical cancer remains a major public health concern worldwide, particularly in low- and middle-income countries. It is predominantly caused by persistent infection with high-risk types of human papillomavirus (HPV). Despite being one of the most preventable and treatable cancers, cervical cancer continues to contribute significantly to cancer-related morbidity and mortality among women. This article provides an in-depth overview of the etiology, risk factors, screening modalities, clinical presentation, staging, and current management strategies of cervical cancer. Special attention is given to HPV vaccination, the role of public health systems, and future directions in treatment and prevention.

References

World Health Organization (2022). Cervical Cancer. https://www.who.int/health-topics/cervical-cancer

Arbyn, M., et al. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health, 8(2), e191–e203.

Schiffman, M., & Castle, P. E. (2005). The promise of global cervical cancer prevention. New England Journal of Medicine, 353(20), 2101–2104.

Saslow, D., et al. (2012). American Cancer Society guidelines for the prevention and early detection of cervical cancer. CA: A Cancer Journal for Clinicians, 62(3), 147–172.

Published

2025-05-20

How to Cite

Nasriddinova Khadichabonu. (2025). CERVICAL CANCER IN WOMEN. Ethiopian International Journal of Multidisciplinary Research, 12(05), 434–435. Retrieved from https://eijmr.org/index.php/eijmr/article/view/3107